Mount Sinai Wins $20.7 Million Deal to Build a Next-Generation Respiratory Vaccine Platform
Mount Sinai researchers have received a five-year, $20.7 million agreement to develop the VITAL vaccine platform, beginning with an intranasal ...
Mount Sinai researchers have received a five-year, $20.7 million agreement to develop the VITAL vaccine platform, beginning with an intranasal ...
A new mass cytometry study reveals that mRNA booster vaccination triggers rapid, lineage-specific immune remodeling within 24 hours, with early ...
New EG95-based mRNA-lipid nanoparticle vaccines induced stronger and longer-lasting immunity against cystic echinococcosis than conventional subunit vaccines in mice and ...
A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a ...
A longitudinal multiomics study of 553 Hong Kong vaccine recipients shows that mRNA-based BNT162b2 produces deeper and more durable gene ...
A new mRNA vaccine strategy called Proactive Immune Training primes the immune system with one antigen and boosts it with ...
Scientists have engineered the envelope protein of human endogenous retrovirus-K to break immune tolerance and drive anti-tumor responses across multiple ...
A Korea University-led clinical study found that an mRNA influenza vaccine sustained germinal-center activity for up to six months in ...
A new review examines the 2026 Andes virus outbreak on the cruise ship MV Hondius, detailing the virus's unique human-to-human ...
Researchers have used immunoinformatics and reverse vaccinology to design a multi-epitope mRNA vaccine candidate against Trypanosoma brucei, the parasite that ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine